Vaping and Ecigs among Behavioral Health Populations: Research Evidence and Research Needs
Associate Professor of Medicine, Stanford Prevention Research Center, Stanford University
Judith (Jodi) Prochaska, PhD, MPH is Associate Professor of Medicine with the Stanford Prevention Research Center and a member of the Stanford Cancer Institute. Dr. Prochaska is a Principal Investigator on multiple research awards from the National Institutes of Health and the State of California Tobacco-Related Disease Research Program. Her research program is leveraging technology (e.g., web, text, social media) to bring tobacco cessation treatment into novel settings and to populations with high smoking prevalence. With attention to medical education and clinical practice, Dr. Prochaska has disseminated tobacco treatment curricula to psychiatry and cardiology training programs as part of Rx for Change (http://rxforchange.ucsf.edu). She has authored over 175 peer-reviewed publications, serves on the Editorial Board of JAMA Internal Medicine, is an editor with the Cochrane Tobacco Addiction Review Group, and is on the advisory board for Optum’s Quit for Life Tobacco Quitline. Dr. Prochaska is immediate past president of the Society for Research on Nicotine and Tobacco (SRNT), the international scientific society aimed at stimulating the generation and dissemination of new knowledge concerning nicotine and tobacco from bench to bedside and through to health policy.
Describe the use rates of vaping and ecigs among behavioral health populations
Review the extant of research on vaping and ecigs among behavioral health populations
Identify research needs to inform clinical practice guidelines regarding vaping and ecigs in behavioral health populations
The CME/CEU registration site is available for the recorded version of this webinar. Click on the orange "Register CME/CEs" button below to register.
Click here to generate a unique certificate of attendance (best viewed in Adobe).
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
The following moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:
Jon Jovi Bodestyne, Christine Cheng, Brian Clark, Jennifer Matekuare, Jessica Safier, Roxana Said, MPH, Catherine Saucedo, and Steven A. Schroeder, MD
The following faculty speaker has disclosed a financial interest/arrangement or affiliation with a commercial company who has provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity. All conflicts of interest have been resolved in accordance with the ACCME Standards for Commercial Support:
Judith J. Prochaska PhD, MPH –
- Pfizer – Consultant
- Carrot – Board Member, Consultant, Stock Shareholder
- MD Revolution – Consultant, Stock Shareholder
- Achieve - Consultant
- Plaintiffs Lawyers – Lawsuits against tobacco companies, Consultant